228 related articles for article (PubMed ID: 11408227)
1. Induction of Epstein-Barr virus kinases to sensitize tumor cells to nucleoside analogues.
Moore SM; Cannon JS; Tanhehco YC; Hamzeh FM; Ambinder RF
Antimicrob Agents Chemother; 2001 Jul; 45(7):2082-91. PubMed ID: 11408227
[TBL] [Abstract][Full Text] [Related]
2. The Epstein-Barr virus (EBV)-encoded protein kinase, EBV-PK, but not the thymidine kinase (EBV-TK), is required for ganciclovir and acyclovir inhibition of lytic viral production.
Meng Q; Hagemeier SR; Fingeroth JD; Gershburg E; Pagano JS; Kenney SC
J Virol; 2010 May; 84(9):4534-42. PubMed ID: 20181711
[TBL] [Abstract][Full Text] [Related]
3. Targeted therapy for Epstein-Barr virus-associated gastric carcinoma using low-dose gemcitabine-induced lytic activation.
Lee HG; Kim H; Kim EJ; Park PG; Dong SM; Choi TH; Kim H; Chong CR; Liu JO; Chen J; Ambinder RF; Hayward SD; Park JH; Lee JM
Oncotarget; 2015 Oct; 6(31):31018-29. PubMed ID: 26427042
[TBL] [Abstract][Full Text] [Related]
4. The Epstein-Barr virus thymidine kinase does not phosphorylate ganciclovir or acyclovir and demonstrates a narrow substrate specificity compared to the herpes simplex virus type 1 thymidine kinase.
Gustafson EA; Chillemi AC; Sage DR; Fingeroth JD
Antimicrob Agents Chemother; 1998 Nov; 42(11):2923-31. PubMed ID: 9797227
[TBL] [Abstract][Full Text] [Related]
5. Experimental treatment of Epstein-Barr virus-associated primary central nervous system lymphoma.
Roychowdhury S; Peng R; Baiocchi RA; Bhatt D; Vourganti S; Grecula J; Gupta N; Eisenbeis CF; Nuovo GJ; Yang W; Schmalbrock P; Ferketich A; Moeschberger M; Porcu P; Barth RF; Caligiuri MA
Cancer Res; 2003 Mar; 63(5):965-71. PubMed ID: 12615710
[TBL] [Abstract][Full Text] [Related]
6. Arginine butyrate-induced susceptibility to ganciclovir in an Epstein-Barr-virus-associated lymphoma.
Mentzer SJ; Fingeroth J; Reilly JJ; Perrine SP; Faller DV
Blood Cells Mol Dis; 1998 Jun; 24(2):114-23. PubMed ID: 9628848
[TBL] [Abstract][Full Text] [Related]
7. (E)-5-(2-bromovinyl)-2'-deoxyuridine potentiates ganciclovir-mediated cytotoxicity on herpes simplex virus-thymidine kinase--expressing cells.
Hamel W; Zirkel D; Mehdorn HM; Westphal M; Israel MA
Cancer Gene Ther; 2001 May; 8(5):388-96. PubMed ID: 11477459
[TBL] [Abstract][Full Text] [Related]
8. Potentiation of ganciclovir toxicity in the herpes simplex virus thymidine kinase/ganciclovir administration system by ponicidin.
Hayashi K; Hayashi T; Sun HD; Takeda Y
Cancer Gene Ther; 2000 Jan; 7(1):45-52. PubMed ID: 10678355
[TBL] [Abstract][Full Text] [Related]
9. Induction of the Epstein-Barr virus thymidine kinase gene with concomitant nucleoside antivirals as a therapeutic strategy for Epstein-Barr virus-associated malignancies.
Faller DV; Mentzer SJ; Perrine SP
Curr Opin Oncol; 2001 Sep; 13(5):360-7. PubMed ID: 11555713
[TBL] [Abstract][Full Text] [Related]
10. Killing effects of ganciclovir on human pulmonary adenocarcinoma cell A549 transduced with HSV1-TK gene in vitro and in vivo.
He XL; Guo XJ; Qian GS; He XH; Huang GJ; Chen WZ; Li SP
Acta Pharmacol Sin; 2001 Oct; 22(10):901-6. PubMed ID: 11749772
[TBL] [Abstract][Full Text] [Related]
11. [Hypoxia responsive element regulated herpes simplex virus-thymidine kinase system enhances killing effect of gancyclovir on Ewing's sarcoma cell line under hypoxic condition].
Si YJ; Guang LX; Yuan FH; Zhang KB
Zhonghua Er Ke Za Zhi; 2006 Aug; 44(8):616-20. PubMed ID: 17083794
[TBL] [Abstract][Full Text] [Related]
12. HSV-tk/GCV gene therapy mediated by EBV-LMP1 for EBV-associated cancer.
Lifang Y; Min T; Midan A; Ya C
J Exp Clin Cancer Res; 2008 Sep; 27(1):42. PubMed ID: 18811956
[TBL] [Abstract][Full Text] [Related]
13. Efficient gene delivery into epstein-barr virus (EBV)-transformed human B cells mediated by replication-defective herpes simplex virus-1 (HSV-1): A gene therapy model for EBV-related B cell malignancy.
Suzuki T; Piche A; Kasono K; Xiang J; Gomez-Navarro J; Moriuchi S; Krisky DM; Oligino T; Glorioso JC; Curiel TJ; Curiel DT
Biochem Biophys Res Commun; 1998 Nov; 252(3):686-90. PubMed ID: 9837767
[TBL] [Abstract][Full Text] [Related]
14. Selection of HSV-1 TK gene-transfected murine mammary carcinoma cells resistant to (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) and ganciclovir (GCV).
Degrève B; De Clercq E; Balzarini J
Gene Ther; 2000 Sep; 7(18):1543-52. PubMed ID: 11021592
[TBL] [Abstract][Full Text] [Related]
15. [Bystander effect mediated by herpes simplex virus-thymidine kinase/ganciclovir approach on prostatic cancer cells and its regulation].
Xing Y; Lu G; Xiao Y; Zeng F; Zhang Q; Xiong P; Feng W
Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(21):1484-7. PubMed ID: 12509912
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the genotoxic and apoptosis-inducing properties of ganciclovir and penciclovir in Chinese hamster ovary cells transfected with the thymidine kinase gene of herpes simplex virus-1: implications for gene therapeutic approaches.
Thust R; Tomicic M; Klöcking R; Voutilainen N; Wutzler P; Kaina B
Cancer Gene Ther; 2000 Jan; 7(1):107-17. PubMed ID: 10678363
[TBL] [Abstract][Full Text] [Related]
17. [Adenovirus-mediated herpes simplex virus thymidine kinase gene transference and combined drug therapy leads to apoptosis of human epithelial ovarian cancer cells].
Jiang J; Kong B; Jiang S
Zhonghua Fu Chan Ke Za Zhi; 2000 Dec; 35(12):736-9. PubMed ID: 11286034
[TBL] [Abstract][Full Text] [Related]
18. Short, discontinuous exposure to butyrate effectively sensitizes latently EBV-infected lymphoma cells to nucleoside analogue antiviral agents.
Ghosh SK; Forman LW; Akinsheye I; Perrine SP; Faller DV
Blood Cells Mol Dis; 2007; 38(1):57-65. PubMed ID: 17161633
[TBL] [Abstract][Full Text] [Related]
19. Lytic induction therapy for Epstein-Barr virus-positive B-cell lymphomas.
Feng WH; Hong G; Delecluse HJ; Kenney SC
J Virol; 2004 Feb; 78(4):1893-902. PubMed ID: 14747554
[TBL] [Abstract][Full Text] [Related]
20. A novel approach for nasopharyngeal carcinoma treatment uses phenylbutyrate as a protein kinase C modulator: implications for radiosensitization and EBV-targeted therapy.
Chung YL; Lee YH; Yen SH; Chi KH
Clin Cancer Res; 2000 Apr; 6(4):1452-8. PubMed ID: 10778977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
